BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17384638)

  • 21. An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced DNA damage.
    Heffernan TP; Simpson DA; Frank AR; Heinloth AN; Paules RS; Cordeiro-Stone M; Kaufmann WK
    Mol Cell Biol; 2002 Dec; 22(24):8552-61. PubMed ID: 12446774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissecting cellular responses to irradiation via targeted disruptions of the ATM-CHK1-PP2A circuit.
    Palii SS; Cui Y; Innes CL; Paules RS
    Cell Cycle; 2013 Apr; 12(7):1105-18. PubMed ID: 23462183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes.
    Zou L; Elledge SJ
    Science; 2003 Jun; 300(5625):1542-8. PubMed ID: 12791985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.
    Gatei M; Sloper K; Sorensen C; Syljuäsen R; Falck J; Hobson K; Savage K; Lukas J; Zhou BB; Bartek J; Khanna KK
    J Biol Chem; 2003 Apr; 278(17):14806-11. PubMed ID: 12588868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
    Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
    Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chk1 and Claspin potentiate PCNA ubiquitination.
    Yang XH; Shiotani B; Classon M; Zou L
    Genes Dev; 2008 May; 22(9):1147-52. PubMed ID: 18451105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity.
    Walker M; Black EJ; Oehler V; Gillespie DA; Scott MT
    Oncogene; 2009 Jun; 28(24):2314-23. PubMed ID: 19421147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status.
    Huntoon CJ; Flatten KS; Wahner Hendrickson AE; Huehls AM; Sutor SL; Kaufmann SH; Karnitz LM
    Cancer Res; 2013 Jun; 73(12):3683-91. PubMed ID: 23548269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirement of MTA1 in ATR-mediated DNA damage checkpoint function.
    Li DQ; Ohshiro K; Khan MN; Kumar R
    J Biol Chem; 2010 Jun; 285(26):19802-12. PubMed ID: 20427275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WRN helicase regulates the ATR-CHK1-induced S-phase checkpoint pathway in response to topoisomerase-I-DNA covalent complexes.
    Patro BS; Frøhlich R; Bohr VA; Stevnsner T
    J Cell Sci; 2011 Dec; 124(Pt 23):3967-79. PubMed ID: 22159421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest.
    Shibata A; Barton O; Noon AT; Dahm K; Deckbar D; Goodarzi AA; Löbrich M; Jeggo PA
    Mol Cell Biol; 2010 Jul; 30(13):3371-83. PubMed ID: 20421415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APE2 is required for ATR-Chk1 checkpoint activation in response to oxidative stress.
    Willis J; Patel Y; Lentz BL; Yan S
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10592-7. PubMed ID: 23754435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
    Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
    Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tipin-replication protein A interaction mediates Chk1 phosphorylation by ATR in response to genotoxic stress.
    Kemp MG; Akan Z; Yilmaz S; Grillo M; Smith-Roe SL; Kang TH; Cordeiro-Stone M; Kaufmann WK; Abraham RT; Sancar A; Unsal-Kaçmaz K
    J Biol Chem; 2010 May; 285(22):16562-71. PubMed ID: 20233725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA-PKcs is required to maintain stability of Chk1 and Claspin for optimal replication stress response.
    Lin YF; Shih HY; Shang Z; Matsunaga S; Chen BP
    Nucleic Acids Res; 2014 Apr; 42(7):4463-73. PubMed ID: 24500207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Claspin is phosphorylated in the Chk1-binding domain by a kinase distinct from Chk1.
    Bennett LN; Larkin C; Gillespie DA; Clarke PR
    Biochem Biophys Res Commun; 2008 May; 369(3):973-6. PubMed ID: 18331829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Claspin and Chk1 regulate replication fork stability by different mechanisms.
    Scorah J; McGowan CH
    Cell Cycle; 2009 Apr; 8(7):1036-43. PubMed ID: 19270516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose deprivation is associated with Chk1 degradation through the ubiquitin-proteasome pathway and effective checkpoint response to replication blocks.
    Kim AJ; Kim HJ; Jee HJ; Song N; Kim M; Bae YS; Chung JH; Yun J
    Biochim Biophys Acta; 2011 Jun; 1813(6):1230-8. PubMed ID: 21440578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of mitotic entry by microcephalin and its overlap with ATR signalling.
    Alderton GK; Galbiati L; Griffith E; Surinya KH; Neitzel H; Jackson AP; Jeggo PA; O'Driscoll M
    Nat Cell Biol; 2006 Jul; 8(7):725-33. PubMed ID: 16783362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy.
    Xiao Z; Xue J; Sowin TJ; Zhang H
    Mol Cancer Ther; 2006 Aug; 5(8):1935-43. PubMed ID: 16928813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.